SPINEMarketGroup

Johnson & Johnson is preparing a potential sale of its orthopedics unit, DePuy Synthes, in a transaction that could exceed $20 billion, according to a source cited by Reuters. The company is said to be positioning private equity firms as the most likely buyers, although it has not publicly commented on the report. Last year, J&J announced plans to separate the orthopedics business … [Read More...] about Johnson & Johnson Explores Potential $20B Sale of DePuy Synthes

Thank you, Syntropiq! On behalf of the SPINEMarketGroup team, we sincerely appreciate your continued support as a PLATINUM sponsor for 2026.We are very proud to continue this journey together for another year! About Syntropiq We are a privately held spine interbody implant and surface technology company. Our team members with rich experience more than 25 years in spine … [Read More...] about We are proud to announce that Syntropiq will once again be a sponsor of SPINEMarketGroup in 2026

Emmanuel Badet--We renamed the management. We made it up, modernized it, dressed it up in seductive words. However, behind this contemporary veneer, many organizations still operate as they did yesterday, simply with more slides, more anglicisms and much more human fatigueLet's be clear-headed. Management sometimes resembles a shadow theatre. We talk about vision, autonomy, inspiration, while on … [Read More...] about Modern Leadership: Lots of light. Little reality

Global C-suite leader brings decades of spinal innovation and PMA experience to support Dymicron's next stage of growth OREM, Utah, Feb. 19, 2026 /PRNewswire/ -- Dymicron®, a privately held medical device company advancing next-generation spinal motion-preservation technology, today announced the appointment of Peter Wehrly, one of the spinal industry's most seasoned C-suite … [Read More...] about Dymicron Appoints Veteran MedTech CEO Peter Wehrly to Board of Directors

The corra™ Cervical Plating System marks the debut of Carlsmed's patient-specific fixation portfolio CARLSBAD, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the first personalized cervical plating procedure using the corra™ Cervical Plating System, the latest addition to its portfolio of personalized spine surgery … [Read More...] about Carlsmed Announces first corra™ personalized Cervical Plating Procedure

Motion-Preserving Lumbar Spine Surgery - Stabilization Without Fusion for Patients with Degenerative Spondylolisthesis SAN CARLOS, Calif., February 18, 2026 (Newswire.com) - The U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) to the LimiFlex™ Dynamic Sagittal Tether, a motion-preserving system for the treatment of lumbar spinal stenosis associated … [Read More...] about FDA Grants PMA Approval to LimiFlex(TM) Dynamic Sagittal Tether

Ecully, February 17, 2026, SPINEWAY 2025 annual results: * 2024 Pro forma: changes to the 2025 French General Chart of Accounts (ANC Regulation 2022-06) required the inclusion in operating income/(loss) of items that were previously recognized in exceptional income and expenses. Additionally, the Research and Innovation tax credits, which were recognized in operating income until 2024, are … [Read More...] about Spineway : 2025 annual results

SAN LUIS OBISPO, Calif., Feb. 18, 2026 /PRNewswire/ -- Fziomed, Inc. ("Fziomed" or the "Company"), a recognized global leader in postsurgical adhesion prevention with the best-in-class synthetic, absorbable gel technology platform, today announced that the Company has surpassed treating one million patients worldwide across its product portfolio over the past 20+ … [Read More...] about Fziomed Commemorates One Millionth Patient Treated With Its Dual-Polymer Adhesion Barrier Technology

GALWAY, Ireland, Feb. 17, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its third quarter (Q3) of fiscal year 2026 (FY26), which ended January 23, 2026. Q3 Key Highlights "Q3 marks another strong quarter, delivering 6% organic revenue growth, ahead of guidance, demonstrating the strength of our portfolio," … [Read More...] about Medtronic reports strong third quarter fiscal 2026 results with highest enterprise revenue growth in 10 quarters